PD-1 inhibitor

Posté 2023-11-22 05:14:13

1KB

Many attempts have been made recently to discover PD-1 inhibitors for treating different kinds of tumors, including but not limited to advanced melanoma and non-small cell lung cancer (NSCLC). The clinical data have shown that these antibodies targeting PD-1 and its ligand PD-L1 can block the activation of T cells and induce anti-tumor activities to improve patients' outcomes in the clinic.

PD-1_inhibitors

Connectez-vous pour aimer, partager et commenter!

Domicile

Luxury Living on Palm Jebel Ali: Exclusive Residences and Amenities

Nestled amidst the shimmering waters of the Arabian Gulf, Palm Jebel Ali stands as an epitome of...

Par 2024-01-10 11:21:32 0 2K

Sports

Sporting Goods Market Review: What to Watch in 2024

As we stride into 2024, the sporting goods market is poised for transformative growth and dynamic...

Par 2024-07-17 08:58:57 0 499

Autre

Global AI Voice Cloning Market Forecast: Projections and Growth Opportunities and 2024 Forecast Study

Global AI Voice Cloning Market: Trends, Growth, and Future Outlook Market Overview The...

Par 2024-10-16 05:14:10 0 241

Autre

Orthopedic Devices Market: The Role of 3D Printing in Production

The global orthopedic devices market was valued at approximately USD 60.4 billion in 2023 and is...

Par 2024-11-21 10:23:53 0 135

Autre

Virtual Production Market: Strategic Insights into the Evolution of Content Production

Virtual Production Market size is expected to reach nearly US $ 7.46 Bn by 2030 with the CAGR of...

Par 2024-11-19 12:01:23 0 143